Health in Kyrgyzstan 1,391 indicators covering health for Kyrgyzstan. IndicatorLatest Year10-yr change Rank Reported number of children receiving antiretroviral therapy 153 2025 down 60.7% 69th Concentrations of fine particulate matter 23.64 2023 down 35.0% 71st Death rate due to road traffic injuries 12.7 per 100,000 population 2019 down 29.4% 109th New or unknown treatment history cases: Pulmonary, bacteriologically 2,191 2023 up 31.4% 89th Medical doctors not further defined 11,101 2024 up 2.5% 53rd Constant stillbirth rate 6.26 2030 unchanged 123rd ENAP target met stillbirth rate 5.3 2030 down 13.2% 123rd Stillbirth rate high-income country 2.8 2030 down 49.8% 1st Stillbirths remain constant projection 941 2030 down 0.6% 98th Stillbirth maintained projection 797 2030 down 13.8% 101st Stillbirth ENAP 2030 target met projection 797 2030 down 13.8% 98th Stillbirth high-income country average rate matched projection 419 2030 down 50.4% 91st Stillbirth rate current trends 5.3 2030 down 13.2% 123rd Life satisfaction vs. life expectancy 71.68 years 2023 up 4.7% 156th Estimate of current cigarette smoking prevalence 15.9% 2030 down 14.5% 62nd Estimate of current cigarette smoking prevalence (%) 16.5% 2030 down 14.1% 61st Tuberculosis patients who tested positive for HIV 126 patients 2021 down 17.6% 79th Number of children aged 6-59 months with anaemia 258.3 2019 up 28.2% 87th Prevalence of anaemia in children aged 6-59 months 33.4% 2019 down 5.4% 77th Mean hemoglobin level of children aged 6-59 months 114 2019 unchanged 119th Estimated number of MDR/RR-TB incident cases 2,600 2024 down 36.6% 20th Neonatal mortality rate - Remains constant 10.79 2030 unchanged 79th Neonatal mortality rate - Current trends maintained 9.25 2030 down 12.0% 81st Neonatal mortality rate - High-income country average rate matched 2.8 2030 down 67.5% 1st Neonatal mortality rate - SDG target met 9.25 2030 down 12.0% 81st Under 5 mortality rate - Remains constant 16.78 2030 unchanged 88th Under 5 mortality rate - Current trends maintained 13.92 2030 down 14.4% 89th Under 5 mortality rate - High-income country average rate matched 5.09 2030 down 62.9% 1st Under 5 mortality rate - SDG target met 13.92 2030 down 14.4% 89th Mortality rate age 10-19 - Remains constant 4.32 2030 down 0.2% 113th Mortality rate age 10-19 - Current trends maintained 4.14 2030 down 3.5% 109th Mortality rate age 10-19 - High-income country average rate matched 2.66 2030 down 32.4% 125th Neonatal deaths - Remains constant 1,612 2030 down 0.1% 84th Neonatal deaths - Current trends maintained 1,382 2030 down 12.1% 85th Neonatal deaths - SDG target met 1,382 2030 down 12.1% 79th Under-five deaths - Remains constant 2,495 2030 down 0.8% 87th Under-five deaths - Current trends maintained 2,069 2030 down 15.1% 88th Under-five deaths - SDG target met 2,069 2030 down 15.1% 83rd Deaths age 10 to 19 - Remains constant 675 2030 up 13.3% 97th Deaths age 10 to 19 - Current trends maintained 646 2030 up 9.3% 93rd Number of deaths attributed to non-communicable diseases, by type of 4,390 2019 up 6.0% 124th Hepatitis B surface antigen (HBsAg) prevalence 0.1% 2024 unchanged 101st Mortality caused by road traffic injury 12.7 per 100,000 population 2019 down 36.2% 109th Mortality caused by road traffic injury, female 6.5 per 100,000 female population 2019 down 30.9% 93rd Mortality caused by road traffic injury, male 18.9 per 100,000 male population 2019 down 38.4% 109th Countries with birth registration data that are at least 90 percent 1 2024 unchanged 2nd Share of one-year-olds who received the inactivated polio vaccine 85.0% 2024 up 57.4% 139th Number of births in thousands 149.48 2025 down 3.0% 27th Deaths in armed conflicts by country, annual growth rate -100 % change on previous year 2023 unchanged 33rd Deaths in armed conflicts by region, annual growth rate -100 % change on previous year 2023 unchanged 33rd Proportion of health care facilities with limited water services 3.32 2025 unchanged 59th Tuberculosis patients living with HIV receiving antiretroviral therapy 77 patients 2021 down 41.2% 84th HIV-positive TB patients on ART (antiretroviral therapy) 85.0% 2024 up 66.7% 106th Hospital beds 37.32 2023 down 21.5% 47th Treatment success rate for patients treated for MDR-TB 75.0% 2022 up 19.0% 70th Treatment success rate: HIV-positive TB cases 66 2023 — 105th Prevalence of wasting, weight for height 3.0% 2023 up 7.1% 66th Estimated number of children (aged 0-17 years) who have lost one or 180,000 2024 up 5.9% 68th Bladder cancer death rate 1.21 deaths per 100,000 people 2023 down 15.8% 71st Cancer death rates by type 1.21 deaths per 100,000 people 2023 down 15.8% 71st ← Previous Page 18 of 24 Next →